相似文献
1
Vaccination and screening programs: harmonizing prevention strategies for HPV-related diseases.
J Exp Clin Cancer Res. 2008 Dec 16;27(1):84. doi: 10.1186/1756-9966-27-84.
2
HPV Update: Vaccination, Screening, and Associated Disease.
J Gen Intern Med. 2016 Nov;31(11):1360-1366. doi: 10.1007/s11606-016-3725-z. Epub 2016 May 16.
3
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Vaccine. 2007 Apr 20;25(16):3007-13. doi: 10.1016/j.vaccine.2007.01.016. Epub 2007 Jan 18.
4
Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
Sex Transm Dis. 2016 Jul;43(7):438-44. doi: 10.1097/OLQ.0000000000000458.
5
Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Vaccine. 2013 Dec 31;31 Suppl 7:H71-9. doi: 10.1016/j.vaccine.2013.04.086.
6
How will HPV vaccines affect cervical cancer?
Nat Rev Cancer. 2006 Oct;6(10):753-63. doi: 10.1038/nrc1973.
7
HPV-vaccine and screening programs: the new era of global prevention.
J Prev Med Hyg. 2009 Jun;50(2):90-5.
8
Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066.
9
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.
10
Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination.
Ghana Med J. 2018 Jun;52(2):94-102. doi: 10.4314/gmj.v52i2.6.
引用本文的文献
1
Trend and survival outcome in Taiwan cervical cancer patients: A population-based study.
Medicine (Baltimore). 2019 Mar;98(11):e14848. doi: 10.1097/MD.0000000000014848.
2
hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
J Exp Clin Cancer Res. 2017 May 25;36(1):71. doi: 10.1186/s13046-017-0541-1.
3
Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors.
Pan Afr Med J. 2015 Jul 30;21:231. doi: 10.11604/pamj.2015.21.231.6350. eCollection 2015.
本文引用的文献
1
The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference.
Vaccine. 2008 Oct 9;26(43):5435-40. doi: 10.1016/j.vaccine.2008.07.077. Epub 2008 Aug 14.
2
Cervical cancer screening following prophylactic human papillomavirus vaccination.
Vaccine. 2008 Mar 14;26 Suppl 1:A16-23. doi: 10.1016/j.vaccine.2007.11.069.
3
EUROGIN 2007 patient education conference: sharing experiences and action in cervical cancer prevention--an overview. Part 2.
Vaccine. 2008 Mar 14;26 Suppl 1:A33-6. doi: 10.1016/j.vaccine.2007.11.075.
4
Human papillomavirus vaccines versus cervical cancer screening.
Clin Oncol (R Coll Radiol). 2008 Aug;20(6):388-94. doi: 10.1016/j.clon.2008.04.006. Epub 2008 Jun 5.
5
Reductions in human papillomavirus-disease resource use and costs with quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study Economic Evaluation.
Value Health. 2008 Dec;11(7):1022-32. doi: 10.1111/j.1524-4733.2008.00342.x. Epub 2008 May 16.
6
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25.
7
HPV and cervical cancer: screening or vaccination?
Br J Cancer. 2008 Jan 15;98(1):15-21. doi: 10.1038/sj.bjc.6604146. Epub 2008 Jan 8.
8
Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S.
Vaccine. 2007 Nov 23;25(48):8110-3. doi: 10.1016/j.vaccine.2007.09.035. Epub 2007 Oct 4.
9
HPV immunisation: a significant advance in cancer control.
Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S1. doi: 10.1016/j.ygyno.2007.07.071.
10
Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Cancer Detect Prev. 2007;31(4):276-81. doi: 10.1016/j.cdp.2007.07.004.
Zotero 插件